CAS 209216-23-9
:Entecavir monohydrate
Description:
Entecavir monohydrate is an antiviral medication primarily used in the treatment of chronic hepatitis B virus (HBV) infection. It is a nucleoside analogue that functions by inhibiting the reverse transcriptase enzyme, thereby preventing viral replication. The chemical formula for entecavir monohydrate reflects its monohydrate form, which includes one molecule of water associated with each molecule of entecavir. This compound is typically presented as a white to off-white crystalline powder, and it is soluble in water, which facilitates its formulation for oral administration. Entecavir exhibits a high barrier to resistance, making it effective against various HBV strains. Its pharmacokinetics indicate a relatively long half-life, allowing for once-daily dosing. Common side effects may include headache, fatigue, and gastrointestinal disturbances, although it is generally well-tolerated. As with any antiviral therapy, monitoring for potential liver function changes is recommended during treatment. Overall, entecavir monohydrate represents a significant advancement in the management of chronic hepatitis B.
Formula:C12H15N5O3·H2O
InChI:InChI=1S/C12H15N5O3.H2O/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20;/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20);1H2/t6-,7-,8-;/m0./s1
InChI key:InChIKey=YXPVEXCTPGULBZ-WQYNNSOESA-N
SMILES:C=C1[C@@H](N2C3=C(N=C2)C(=O)N=C(N)N3)C[C@H](O)[C@H]1CO.O
Synonyms:- 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
- 2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3,9-dihydro-6H-purin-6-one hydrate (1:1)
- 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, hydrate (1:1)
- 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, monohydrate
- Entecavir Monohydrate
- Enticavir hydrate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 14 products.
ENTECAVIR FOR SYSTEM SUITABILITY CRS
CAS:<p>ENTECAVIR FOR SYSTEM SUITABILITY CRS</p>Formula:C12H15N5O3Color and Shape:Powder. White. Whitish.Molecular weight:277.2792Entecavir Monohydrate
CAS:<p>Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure</p>Formula:C12H15N5O3·H20Color and Shape:White Off-White PowderMolecular weight:277.117496H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, hydrate (1:1)
CAS:Formula:C12H17N5O4Purity:98%Color and Shape:SolidMolecular weight:295.2945Entecavir monohydrate
CAS:<p>Entecavir monohydrate (BMS-200475) is a selective inhibitor of the replication of the hepatitis B virus (HBV). It, a new deoxyguanine nucleoside analog.</p>Formula:C12H15N5O3·H2OPurity:99.73% - >99.99%Color and Shape:White Crystalline PowderMolecular weight:295.3Entecavir hydrate
CAS:Formula:C12H15N5O3·xH2OPurity:≤ 0.1%Color and Shape:White to off-white powderMolecular weight:277.28 (anhydrous)Entecavir Monohydrate
CAS:Formula:C12H15N5O3·H2OPurity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:295.30Entecavir Monohydrate
CAS:Controlled ProductFormula:C12H15N5O3·H2OColor and Shape:NeatMolecular weight:295.29Entecavir Monohydrate
CAS:Controlled Product<p>Applications Entecavir Monohydrate (cas# 209216-23-9) is a useful research chemical.<br></p>Formula:C12H15N5O3·H2OColor and Shape:Off White SolidMolecular weight:295.29Entecavir hydrate
CAS:<p>Nucleoside reverse transcriptase inhibitor; anti-Hepatitis B virus</p>Formula:C12H15N5O3·xH2OPurity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:277.28 g/mol












